Health Research Authority reports on the early intervention study
17 October 2019
The Tavistock and Portman takes the integrity of its clinical practice and research very seriously. Our work conforms to the highest legal, ethical and regulatory standards and our priority is the safety and wellbeing of our patients at all times.
We welcome the findings of a
recent Health Research Authority (HRA) report, which concludes that for the Early Intervention
Study carried out at our Gender Identity Development Service (GIDS), the researchers
worked in accordance with recognised best practice
for health research. We also welcome the acknowledgement that in some areas,
such as patient involvement and transparency, the researchers were ahead of
normal practice at the time.
The early intervention study was undertaken after nearly a decade of consultation with international experts, was fully approved by a research ethics committee and has followed good research practice. The study group has presented aspects of interim data at professional conferences since 2015 and the full study results will be published in a peer-reviewed journal in line with international best practice.
The GIDS is one of the longest-established services of its type in the world with an international reputation for being cautious and considered. Our clinical interventions are laid out in nationally-set service specifications. The Care Quality Commission (CQC), our care standards regulator, and our national commissioners, NHS England, monitor our service very closely. The Service has a high level of reported satisfaction and was rated Good by the CQC.
For children and young people, and their families, who experience difficulties in the development of their gender identity.